The human brain has long been regarded as one of the most versatile parts of the body due to neuroplasticity. This is basically the concept where people can change the properties of their gray matter by introducing particular stimuli. In recent research papers, scientists are seeing indications that meditating can lead to a brain that is decades younger than the body and a heightened level of selflessness.
As Futurism notes, there have been numerous studies related to the effects of meditation on neuroplasticity. One of these is the Johns Hopkins School of Public Health study that found how meditation can help decrease anxiety and depression just as well as drugs.
There are also studies that note how meditation can affect certain parts of the brain in order to make them seem younger. There were even cases where patients 50 years of age had similar gray matter levels to those 25 years their junior. One of the biggest benefits to this kind of result includes the prevention of dementia or some other type of neurological degradation.
With regards to the psychological effects of meditation, it has long been accepted that the practice is meant to encourage peace of mind. However, a Yale study also discovered that it can make people less selfish. The study also found that it helped to increase concentration as well as to be more considerate of others.
Even overcoming smoking addiction has been the subject of research involving meditation, with some cases reporting success rates of 60 percent. The same goes for cases where self-control is an issue, so it basically applies to pretty much any kind of addiction.
All in all, numerous scientific literature are now suggesting that meditation is a solution to many of the problems that people often address via drugs or some other form of addictive activity. Heck, it can even supplant exercise, though, it’s always best to combine both.


Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
CDC Expands Ebola Screening Efforts at U.S. Entry Points Amid Congo and Uganda Outbreak
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
3 clinical-grade skincare creams you really shouldn’t buy online
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
Should I take zinc or eat oysters to ward off colds, boost my immune system or improve fertility?
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak 



